Brief: Aprea Therapeutics Q2 EPS USD -0.87
10/08/2023 12:36
Aug 10 (Reuters) - Aprea Therapeutics Q2 operating income USD -3,651.681 million. * Q2 net income USD -3,259.097 million * Q2 EPS USD -0.87
Recent news on Aprea Therapeutics
See all newsAprea Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aprea Therapeutics Q2 net loss widens on higher R&D costs
Aprea Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026
Brief: Aprea Therapeutics - Files For Resale Of Up To 5.5 Million Shares By Selling Stockholders - SEC Filing